Wang, R., Chen, S., Huang, L., Zhou, Y., & Shao, Z. (2018). Monitoring Serum VEGF in Neoadjuvant Chemotherapy for Patients with Triple‐Negative Breast Cancer: A New Strategy for Early Prediction of Treatment Response and Patient Survival. Oncologist.
Citación estilo ChicagoWang, Ruo‐Xi, Sheng Chen, Liang Huang, Ying Zhou, y Zhi‐Ming Shao. "Monitoring Serum VEGF in Neoadjuvant Chemotherapy for Patients With Triple‐Negative Breast Cancer: A New Strategy for Early Prediction of Treatment Response and Patient Survival." Oncologist 2018.
Cita MLAWang, Ruo‐Xi, et al. "Monitoring Serum VEGF in Neoadjuvant Chemotherapy for Patients With Triple‐Negative Breast Cancer: A New Strategy for Early Prediction of Treatment Response and Patient Survival." Oncologist 2018.